Abstract
Studies attempting to delineate a therapeutic range of blood levels for neuroleptics have yielded conflicting results. The reasons for this are briefly reviewed and a study is described in which a correlation is sought between blood levels of thioridazine and clinical efficacy. The study employs the radioreceptor assay for neuroleptics to detect both parent drug and active metabolites in blood. The results of the study indicate that while dose is a poor predictor of blood levels of medication, blood levels of neuroleptic activity in patients on thioridazine may be very highly correlated with antipsychotic effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baldessarini RJ (1977) Chemotherapy in Psychiatry. Harvard University Press, Cambridge, MA
Cohen BM, Herschel M, Aoba A (1979) Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites. Psychiatry Research 1:199–208
Cohen BM, Lipinski JF, Harris PQ, Pope HG, Friedman M (1980a) Clinical use of the radioreceptor assay for neuroleptics. Psychiatry Research 2:173–178
Cohen BM, Herschel M, Miller EM, Baldessarini R (1980b) Radioreceptor assay of haloperidol tissue levels in the rat. Neuropharmacology 19:663–668
Cooper TB, Simpson GM, Lee JH (1976) Thymoleptic and neuroleptic drug plasma levels in psychiatry: current status. Int Rev Neurobiol 19:269–309
Cresse I, Snyder SH (1977) A novel, simple and sensitive radioreceptor assay for antischizophrenic drugs in blood. Nature 270:180–182
Davis MM, Erickson S, Dekirmenjian H (1978) Plasma levels of antipsychotic drugs and clinical response. In: Lipton MA, Dimascio A, Killiam KF (eds) Psychopharmacology: A Generation of Progress, Raven Press, New York
Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26:57–63
Garver DL, Dekirmenjian H, Davis JM, Casper R, Erickson S (1977) Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine. Am J Psychiatry 134:304–307
Lader M (1976) Monitoring plasma concentrations in neuroleptics. Pharmakopsychiatr 9:170–177
May PRA, Van Putten T (1978) Plasma levels of chlorpromazine in schizophrenia. Arch Gen Psychiatry 35:1081–1087
Overall JE, Gorham DP (1962) The brief psychiatric rating scale (BPRS). Psychol Rep 10:799–812
Author information
Authors and Affiliations
Additional information
This work was supported in part by USPHS Grants MH-31154, and Grants from the Scottish Rite Schizophrenia Research Program NMJ, USA
Rights and permissions
About this article
Cite this article
Cohen, B.M., Lipinski, J.F., Pope, H.G. et al. Neuroleptic blood levels and therapeutic effect. Psychopharmacology 70, 191–193 (1980). https://doi.org/10.1007/BF00435313
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00435313